Scientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.The development of the compound, called WEHI-539, is an important step towards the design of a potential new anti-cancer agent.
Fuente : http://www.eurekalert.org/pub_releases/2013-04/wae...
Fuente : http://www.eurekalert.org/pub_releases/2013-04/wae...